Skip to main content
. 2022 May 24;9(1):e001936. doi: 10.1136/openhrt-2021-001936

Figure 2.

Figure 2

Allocation and follow-up of trial participants in the impact of dapagliflozine treatment on renal function and diuretics use in acute decompensated heart failure. Values are mean±SD or n. AHF, acute heart failure; eGFR, estimated glomerular filtration rate; SGLT2i, sodium-dependent glucose type 2 cotransporter inhibitors; TD1M, type 1 diabetes mellitus.